Neoantigen-directed immune escape in lung cancer evolution.
Rosenthal R, Cadieux EL, Salgado R, Bakir MA, Moore DA, Hiley CT, Lund T, Tanić M, Reading JL, Joshi K, Henry JY, Ghorani E, Wilson GA, Birkbak NJ, Jamal-Hanjani M, Veeriah S, Szallasi Z, Loi S, Hellmann MD, Feber A, Chain B, Herrero J, Quezada SA, Demeulemeester J, Van Loo P, Beck S, McGranahan N, Swanton C, TRACERx consortium.
Nature
567 :
2019
479-485
747
Understanding the impact of immune-mediated selection on lung cancer evolution.
Rosenthal R, Swanton C, McGranahan N.
Br J Cancer
124 :
2021
1615-1617
6
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.
Cao S, Wang JR, Ji S, Yang P, Dai Y, Guo S, Montierth MD, Shen JP, Zhao X, Chen J, Lee JJ, Guerrero PA, Spetsieris N, Engedal N, Taavitsainen S, Yu K, Livingstone J, Bhandari V, Hubert SM, Daw NC, Futreal PA, Efstathiou E, Lim B, Viale A, Zhang J, Nykter M, Czerniak BA, Brown PH, Swanton C, Msaouel P, Maitra A, Kopetz S, Campbell P, Speed TP, Boutros PC, Zhu H, Urbanucci A, Demeulemeester J, Van Loo P, Wang W.
Nat Biotechnol
40 :
2022
1624-1633
58
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer.
Kraemer AI, Chong C, Huber F, Pak H, Stevenson BJ, Müller M, Michaux J, Altimiras ER, Rusakiewicz S, Simó-Riudalbas L, Planet E, Wiznerowicz M, Dagher J, Trono D, Coukos G, Tissot S, Bassani-Sternberg M.
Nat Cancer
4 :
2023
608-628
62
Human endogenous retrovirus onco-exaptation counters cancer cell senescence through calbindin.
Attig J, Pape J, Doglio L, Kazachenka A, Ottina E, Young GR, Enfield KS, Aramburu IV, Ng KW, Faulkner N, Bolland W, Papayannopoulos V, Swanton C, Kassiotis G.
J Clin Invest
133 :
2023
e164397
29
Multimodal analysis unveils tumor microenvironment heterogeneity linked to immune activity and evasion.
Lapuente-Santana Ó, Sturm G, Kant J, Ausserhofer M, Zackl C, Zopoglou M, McGranahan N, Rieder D, Trajanoski Z, da Cunha Carvalho de Miranda NF, Eduati F, Finotello F.
iScience
27 :
2024
110529
7
Multiregional transcriptomic profiling provides improved prognostic insight in localized non-small cell lung cancer.
Li C, Nguyen TT, Li JR, Song X, Fujimoto J, Little L, Gumb C, Chow CB, Wistuba II, Futreal AP, Zhang J, Hubert SM, Heymach JV, Wu J, Amos CI, Zhang J, Cheng C.
NPJ Precis Oncol
8 :
2024
225
3
Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression.
Agrawal D, Cisarova K, Vosberg S, Allmendinger F, Munkhbaatar E, Dandachi N, Fernandez Hernandez FJ, Tonietto M, Jäger V, Anton M, Keller EC, Jesinghaus M, Meinhardt AL, Haefner V, Stoeger T, Steiger K, McGranahan N, Dengler MA, Wahida A, Jost PJ.
Sci Adv
12 :
2026
eadz9227
1
A multi-branch ensemble learning framework for detection of non-small cell lung cancer via T-cell receptor sequencing.
Wang W, Hu X, Luan Y, Chen W, Zhu Q, Tian G, Zheng Q, Meng J, Wang C, Wang M.
BMC Cancer
26 :
2026
372
0
